收稿日期: 2024-07-31
网络出版日期: 2024-12-18
基金资助
国家自然基金(82171780);广东省基础与应用基础研究基金(2023A1515030253);广东省基础与应用基础研究基金(2414050002681)
版权
Clinical characteristics of overlapping syndromes of low muscle mass in patients with rheumatoid arthritis and their impact on physical function
Received date: 2024-07-31
Online published: 2024-12-18
Supported by
National Natural Science Foundation of China(82171780);Basic and Applied Basic Research Foundation of Guangdong Province(2023A1515030253);Basic and Applied Basic Research Foundation of Guangdong Province(2414050002681)
Copyright
目的: 探讨类风湿关节炎(rheumatoid arthritis,RA)患者合并低肌肉量综合征的特征及其对躯体功能的影响。方法: 纳入2019年9月至2024年4月就诊于中山大学孙逸仙纪念医院风湿免疫科的RA患者。收集所有患者的临床资料,包括病情活动、躯体功能及放射学评估,同时进行身体成分、握力和步行速度的测量,评估有无低肌肉量综合征以及营养不良、肌少症、肌少症性肥胖和恶病质,采用斯坦福健康评估问卷-残疾指数(health assessment questionnaire-disability index,HAQ-DI)评估躯体功能,并通过Logistic回归分析躯体功能障碍的影响因素。结果: 共纳入RA患者1 016例,女性占82.5%,平均年龄(52.4±12.5)岁。557例(54.8%)为低肌肉量综合征且均合并营养不良,在此基础上,326例(32.1%)合并肌少症,124例(12.2%)合并肌少症性肥胖,33例(3.2%)合并恶病质。共584例(57.4%)RA患者有躯体功能障碍,轻度、中度和重度躯体功能障碍分别有421例(41.4%)、124例(12.2%)和39例(3.8%)。与无低肌肉量综合征(n=459)或仅营养不良(n=231)的患者相比,同时合并营养不良+肌少症(n=326)的RA患者病情活动性高,躯体功能障碍比例较高(69.6% vs. 42.0% vs. 56.6%),但仅营养不良的RA患者HAQ-DI评分(中位数0.0 vs. 0.1)和躯体功能障碍比例(42.0% vs. 56.6%)则较无低肌肉量综合征者低。多因素Logistic回归分析显示,营养不良+肌少症与躯体功能障碍呈独立正相关(OR=2.021,95%CI:1.067~3.828),而仅营养不良则与躯体功能障碍无明显相关。结论: 同时合并营养不良和肌少症会加重RA患者病情活动性和躯体功能障碍,临床应重视RA患者低肌肉量综合征尤其是肌少症的筛查与评估,并予以及时干预。
贾霈雯 , 杨迎 , 邹耀威 , 欧阳志明 , 林建子 , 马剑达 , 杨葵敏 , 戴冽 . 类风湿关节炎患者低肌肉量综合征的临床特征及其对躯体功能的影响[J]. 北京大学学报(医学版), 2024 , 56(6) : 1009 -1016 . DOI: 10.19723/j.issn.1671-167X.2024.06.010
Objective: To investigate the clinical characteristics of overlapping syndromes of low muscle mass in Chinese patients with rheumatoid arthritis (RA) and their impact on physical function. Methods: Consecutive patients with RA were recruited from September 2019 to April 2024 at Department of Rheumatology and Immunology, Sun Yat-Sen Memorial Hospital. Clinical data including disease acti-vity, physical function and radiographic assessment were collected. All patients also finished measurement of body composition, grip strength, and gait speed, and overlapping syndromes of low muscle mass as well as malnutrition, sarcopenia, sarcopenic obesity, and cachexia were evaluated. The Stanford health assessment questionnaire- disability index (HAQ-DI) was used to evaluate physical function. Logistic regression was used to analyze the related factors of physical dysfunction. Results: A total of 1 016 RA patients were recruited. Their mean age was (52.4±12.5) years, and 82.5% were female. There were 557 cases (54.8%) with overlapping syndromes of low muscle mass and all of them were malnutrition. On this basis, 326 cases (32.1%) exhibited sarcopenia, 124 (12.2%) sarcopenic obesity, and 33 (3.2%) cachexia. There were 584 (57.4%) of RA patients having physical dysfunction, with varying degrees of severity 421 (41.4%) mild, 124 (12.2%) moderate, and 39 (3.8%) severe. Compared with patients without overlapping syndromes of low muscle mass (n=459) or with malnutrition only (n=231), RA patients with both malnutrition and sarcopenia (n=326) had significantly higher core disease activity indicators and higher rate of physical dysfunction (69.6% vs. 42.0% vs. 56.6%). However, compared with patients without overlapping syndromes of low muscle mass, patients with malnutrition only had lower HAQ-DI score (median 0.0 vs. 0.1) and lower rate of physical dysfunction (42.0% vs. 56.6%). Multivariate Logistic regression analysis showed that simultaneously overlapping malnutrition and sarcopenia were associated factors of physical dysfunction (OR=2.021, 95%CI: 1.067-3.828), but malnutrition only was not. Conclusion: Simultaneously overlapping malnutrition and sarcopenia can deteriorate disease activity and physical dysfunction in RA patients. The screening and evaluation of overlapping syndromes of low muscle mass, especially sarcopenia should be emphasized in patients with RA.
| 1 | 耿研, 谢希, 王昱, 等. 类风湿关节炎诊疗规范[J]. 中华内科杂志, 2022, 61 (1): 51- 59. |
| 2 | 周云杉, 王秀茹, 安媛, 等. 全国多中心类风湿关节炎患者残疾及功能受限情况的调查[J]. 中华风湿病学杂志, 2013, 17 (8): 526- 532. |
| 3 | 邹耀威, 连舒燕, 陈楚涛, 等. 类风湿关节炎患者功能受限特征及相关因素分析[J]. 中华内科杂志, 2022, 61 (2): 193- 199. |
| 4 | Smolen JS , Breedveld FC , Burmester GR , et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force[J]. Ann Rheum Dis, 2015, 75 (1): 3- 15. |
| 5 | Bennett JL , Pratt AG , Dodds R , et al. Rheumatoid sarcopenia: Loss of skeletal muscle strength and mass in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2023, 19 (4): 239- 251. |
| 6 | Elkan AC , Engvall IL , Tengstrand B , et al. Malnutrition in women with rheumatoid arthritis is not revealed by clinical anthropometrical measurements or nutritional evaluation tools[J]. Eur J Clin Nutr, 2007, 62 (10): 1239- 1247. |
| 7 | Tański W , Wójciga J , Jankowska-Polańska B . Association between malnutrition and quality of life in elderly patients with rheumatoid arthritis[J]. Nutrients, 2021, 13 (4): 1259. |
| 8 | Baker JF , George M , Baker DG , et al. Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis[J]. Rheumatology, 2011, 50 (11): 2100- 2107. |
| 9 | Cederholm T , Jensen GL , Correia MITD , et al. GLIM criteria for the diagnosis of malnutrition: A consensus report from the global clinical nutrition community[J]. Clin Nutr, 2019, 38 (1): 1- 9. |
| 10 | Chew STH , Tey SL , Yalawar M , et al. Prevalence and associated factors of sarcopenia in community-dwelling older adults at risk of malnutrition[J]. BMC Geriatr, 2022, 22 (1): 997. |
| 11 | Ngeuleu A , Allali F , Medrare L , et al. Sarcopenia in rheumatoid arthritis: Prevalence, influence of disease activity and associated factors[J]. Rheumatol Int, 2017, 37 (6): 1015- 1020. |
| 12 | Giles JT , Ling SM , Ferrucci L , et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: Association with disease characteristics and pharmacotherapies[J]. Arthritis Rheum, 2008, 59 (6): 807- 815. |
| 13 | Torii M , Hashimoto M , Hanai A , et al. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis[J]. Mod Rheumatol, 2019, 29 (4): 589- 595. |
| 14 | Santo RCE , Fernandes KZ , Lora PS , et al. Prevalence of rheumatoid cachexia in rheumatoid arthritis: A systematic review and meta-analysis[J]. J Cachexia Sarcopenia Muscle, 2018, 9 (5): 816- 825. |
| 15 | Arnett FC , Edworthy SM , Bloch DA , et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum, 1988, 31 (3): 315- 324. |
| 16 | Aletaha D , Neogi T , Silman AJ , et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Ann Rheum Dis, 2010, 69 (9): 1580- 1588. |
| 17 | Lin JZ , Liang JJ , Ma JD , et al. Myopenia is associated with joint damage in rheumatoid arthritis: A cross-sectional study[J]. J Cachexia Sarcopenia Muscle, 2019, 10 (2): 355- 367. |
| 18 | Oliveros E , Somers VK , Sochor O , et al. The concept of normal weight obesity[J]. Prog Cardiovasc Dis, 2014, 56 (4): 426- 433. |
| 19 | Abizanda P , Navarro JL , García-Tomás MI , et al. Validity and usefulness of hand-held dynamometry for measuring muscle strength in community-dwelling older persons[J]. Arch Gerontol Geriatr, 2012, 54 (1): 21- 27. |
| 20 | Chen LK , Woo J , Assantachai P , et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21 (3): 300- 307. |
| 21 | Donini LM , Busetto L , Bischoff SC , et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement[J]. Clin Nutr, 2022, 41 (4): 990- 1000. |
| 22 | Evans WJ , Morley JE , Argilés J , et al. Cachexia: A new definition[J]. Clin Nutr, 2008, 27 (6): 793- 799. |
| 23 | Li TH , Chang YS , Liu CW , et al. The prevalence and risk factors of sarcopenia in rheumatoid arthritis patients: A systematic review and meta-regression analysis[J]. Semin Arthritis Rheu, 2020, 51 (1): 236- 245. |
| 24 | Challal S , Minichiello E , Boissier MC , et al. Cachexia and adiposity in rheumatoid arthritis. Relevance for disease management and clinical outcomes[J]. Joint Bone Spine, 2016, 83 (2): 127- 133. |
| 25 | Tian P , Xiong J , Wu W , et al. Impact of the malnutrition on mortality in rheumatoid arthritis patients: A cohort study from NHANES 1999-2014[J]. Front Nutr, 2023, 9, 993061. |
| 26 | Rall LC , Roubenoff R . Rheumatoid cachexia: Metabolic abnormalities, mechanisms and interventions[J]. Rheumatology, 2004, 43 (10): 1219- 1223. |
| 27 | Jutley GS , Sahota K , Sahbudin I , et al. Relationship between inflammation and metabolism in patients with newly presenting rheumatoid arthritis[J]. Front Immunol, 2021, 12, 676105. |
| 28 | Cano-García L , Manrique-Arija S , Domínguez-Quesada C , et al. Sarcopenia and nutrition in elderly rheumatoid arthritis patients: A cross-sectional study to determine prevalence and risk factors[J]. Nutrients, 2023, 15 (11): 2440. |
| 29 | Pan J , Wu T , Ma JD , et al. Geriatric nutrition risk index: A more powerful index identifying muscle mass loss in patients with rheumatoid arthritis[J]. Clin Rheumatol, 2024, 43 (4): 1299- 1310. |
| 30 | Engvall IL , Elkan AC , Tengstrand B , et al. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical dis-ability, and low bioavailable insulin-like growth factor[J]. Scand J Rheumatol, 2008, 37 (5): 321- 328. |
| 31 | Baker JF , Giles JT , Weber D , et al. Sarcopenic obesity in rheumatoid arthritis: Prevalence and impact on physical functioning[J]. Rheumatology (Oxford), 2022, 61 (6): 2285- 2294. |
| 32 | Pan J , Zou YW , Zhu YY , et al. Muscle mass loss is associated with physical dysfunction in patients with early rheumatoid arthritis[J]. Front Nutr, 2022, 9, 1007184. |
| 33 | Dent E , Morley JE , Cruz-Jentoft AJ , et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, diagnosis and management[J]. J Nutr Health Aging, 2018, 22 (10): 1148- 1161. |
| 34 | Liao CD , Chen HC , Huang SW , et al. Exercise therapy for sarcopenia in rheumatoid arthritis: A meta-analysis and meta-regression of randomized controlled trials[J]. Clin Rehabil, 2002, 36 (2): 145- 157. |
| 35 | Rausch Osthoff AK , Juhl CB , Knittle K , et al. Effects of exercise and physical activity promotion: Meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip/knee osteoarthritis[J]. RMD Open, 2018, 4 (2): e000713. |
| 36 | Deutz NE , Bauer JM , Barazzoni R , et al. Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group[J]. Clin Nutr, 2014, 33 (6): 929- 936. |
| 37 | Groen BB , Horstman AM , Hamer HM , et al. Post-prandial protein handling: You are what you just ate[J]. PLoS One, 2015, 10 (11): e0141582. |
| 38 | De Spiegeleer A , Beckwée D , Bautmans I , et al. Sarcopenia Guidelines Development group of the Belgian Society of Gerontology and Geriatrics (BSGG). Pharmacological interventions to improve muscle mass, muscle strength and physical performance in older people: An umbrella review of systematic reviews and meta-analyses[J]. Drugs Aging, 2018, 35 (8): 719- 734. |
/
| 〈 |
|
〉 |